Abstract
Objective
To determine the relationship between subcutaneous fat, visceral fat surface area
(VFA), bladder wall fat distribution, and visceral adiposity index (VAI) as risk factors
for overactive bladder (OAB) occurrence.
Patients and Methods
A cross-sectional study involved 157 participants was conducted. The participants
were divided into 2 groups; study group (87 patients diagnosed with OAB) and control
group (70 healthy participants). All participants were evaluated for OAB using short-form
OABSS version. Physical examination including waist circumference (WC) measurement
in addition to metabolic laboratory investigations (eg, High density lipoprotein (HDL),
cholesterol, etc) were done. Study group underwent urodynamic testing. Using noncontrast
spiral CT abdomen and pelvis, trunkal fat measurements and bladder wall fat distribution
were detected. VAI was calculated for both females and males. Univariate and multivariate
analyses were done to detect risk factors for OAB occurrence. Correlation between
all factors and total OABSS and urodynamics was done.
Results
The mean age ± SD was 40.4 ± 9 years. In multivariate analysis, increased VFA, higher
cholesterol level, increased VAI and focal fat distribution at bladder wall were associated
with 9.4, 1.98, 5.5, and 1.6 times higher risk for OAB occurrence. VAI and VFA were
strongly correlated with total OABSS, DLPP, amplitude, and frequency of bladder detrusor
contractions. On the other hand, WC and body mass index were not correlated significantly.
Conclusion
Body mass index and WC are crude inaccurate methods correlated with OAB presence.
Focal bladder wall fat distribution, higher VAI, higher VFA are novel risk factors
for OAB occurrence. Both VAI and VFA are correlated significantly to total OABSS and
urodynamics findings in patients with OAB.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The overactive bladder and the AUA guidelines: a proposed clinical pathway for evaluation and effective management in a contemporary urology practice.Urol Pract. 2016; 3: 399-405
- Summary of European Association of Urology (EAU) guidelines on neuro-urology.Eur Urol. 2016; 69: 324-333
- A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women.Neurourol Urodyn. 2008; 27: 749-757
- Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.BJU Int. 2012; 110: 540-545
- The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey.J Urol. 2011; 185: 955-963
- BMI, waist circumference, and incident urinary incontinence in older women.Obesity. 2008; 16: 881-886
- Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies.Int J Clin Pract. 2015; 69: 199-217
- Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.Endocr Rev. 2000; 21: 697-738
- The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population.Int Urogynecol J. 2011; 22: 569-575
- Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle‐aged women.BJOG. 2004; 111: 600-604
- Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms.Urology. 2019; 123: 34-43
- Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women.Age Ageing. 2005; 35: 16-24
- Metabolic syndrome in female patients with overactive bladder.Urology. 2012; 79: 72-75
- Bowel wall fat halo sign in patients without intestinal disease.Am J Roentgenol. 2003; 181: 781-784
- Stress urinary incontinence and visceral adipose index: a new risk parameter.Int Urol Nephrol. 2014; 46: 2297-2300
- Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.Diabetes Care. 2010; 33: 920-922
- Overactive bladder–18 years–Part II.Int Braz J Urol. 2016; 42: 199-214
- Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.Neurourol Urodyn. 2002; 21: 261-274
- Bladder wall fat on computed tomography with pathologic correlation.Clin Imaging. 2013; 37: 509-513
- An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.Neurourol Urodyn. 2010; 29: 4-20
- A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment.Eur Urol. 2019; 75: 988-1000
- Relationship between body mass index and overactive bladder in women and correlations with urodynamic evaluation.Int Neurourol J. 2012; 16: 126
Article Info
Publication History
Published online: May 28, 2020
Accepted:
April 29,
2020
Received:
January 8,
2020
Footnotes
Clinical trial no: NCT03750604.
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
